Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FAI Insert in chronic non-infectious posterior uveitis
NCT02746991Phase 3Completed
- Sponsor
- EyePoint Pharmaceuticals
- Start
- Jun 2015
- Primary completion
- Oct 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of fluocinolone in posterior uveitis, intermediate uveitis (IU), panuveitis, sponsored by EyePoint Pharmaceuticals. Started Jun 2015; status: completed.
02
Drugs
fluocinolone
03
Conditions
posterior uveitisintermediate uveitis (IU)panuveitis
Beyond the preview
Go deeper on NCT02746991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02746991.